Medicine & Health

Researchers at WashU Medicine have found a strong correlation between obesity in one or both parents during pregnancy and their child’s risk of developing a common liver disorder.

Washington University in St. Louis and University of Health Sciences and Pharmacy announced they have entered into an agreement whereby WashU will assume control of UHSP. UHSP’s central program, the Doctor of Pharmacy, will become WashU’s 10th academic school, to be known as WashU St. Louis College of Pharmacy.

Denise M.S. Willers, MD, a clinician renowned for patient-centered care and academic excellence, has been named the new director of the WashU Medicine Division of Academic Specialists in Obstetrics & Gynecology.

Michael J. Greenberg, at WashU Medicine, has received two grants from the National Institutes of Health (NIH) to investigate the complex roles of troponin — a critical protein in the heart — in various forms of heart failure.

Philip Payne, vice chancellor for biomedical informatics and data science at WashU Medicine and chief health AI officer for BJC Health and WashU Medicine, will lead the American Medical Informatics Association.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.

Padma Gulur, MD, a physician-scientist and nationally recognized leader in pain management, has been named the head of the Department of Anesthesiology and the inaugural Alex S. Evers MD Distinguished Professor in Anesthesiology at WashU Medicine. Her appointment begins Aug. 1.

A study by researchers at WashU Medicine reveals how the body reprograms stable fat cells to eliminate stubborn fat reserves.

A brain network first identified by WashU Medicine researchers, called SCAN, is shown in a new study to be the neurological basis for Parkinson’s disease. Patients receiving treatments targeted to this brain region, rather than to surrounding areas, experienced greater improvements in symptoms.

The program in Microbial, Immunologic and Neurologic Disorders is accepting joint proposals from researchers at WashU Medicine and the Weizmann Institute of Science to execute collaborative research projects. Submissions are due March 31.